ASB4

ASB4 is the substrate-recognition subunit of an elongin B/elongin C/cullin/Roc E3 ubiquitin ligase complex that targets specific proteins for ubiquitination and proteasomal degradation, coupling oxygen sensing and metabolic signaling to differentiation and energy homeostasis (PMID:17636018, PMID:11111040). Its ligase activity is regulated by oxygen tension: FIH hydroxylates an asparagine residue in ASB4 in normoxia, an oxygen-dependent modification linked to substrate binding and degradation (PMID:17636018). Through its SOCS box, ASB4 ubiquitinates and degrades the transcriptional regulator ID2 in trophoblasts, driving trophoblast differentiation and placental vascular patterning, and a degradation-resistant ID2 mutant blocks both responses (PMID:24586788); loss of ASB4 allows insulin to elevate ID2 post-transcriptionally, linking the pathway to preeclampsia pathology (PMID:36768469). In hypothalamic POMC and NPY neurons, ASB4 binds and ubiquitinates IRS4 in a SOCS box-dependent manner to dampen insulin/AKT signaling (PMID:21955513), and acts downstream of AgRP to regulate satiety—being suppressed by fasting, required for calcitonin-induced meal termination via Calcr expression, and controlling glucose homeostasis in POMC neurons (PMID:35536884). Separately, ASB4 engages GPS1/CSN1 through its ankyrin-repeat domain, independent of the SOCS box, to suppress JNK activity and reduce IRS-1 serine phosphorylation (PMID:17276034).

1. 2002 Medium

   Established Asb4 as an imprinted gene, the first indication that its expression is under parent-of-origin genomic control.

   Evidence RIKEN cDNA microarray of parthenogenetic vs androgenetic embryos with reciprocal F1 cross validation

   PMID:11820791

   Open questions at the time

   • No mechanism of imprinting (DMR, methylation) characterized
   • No link drawn between imprinting and ASB4 protein function
2. 2007 Medium

   Defined the core molecular identity of ASB4 as a SOCS-box E3 ubiquitin ligase substrate-recognition subunit and tied its activity to oxygen via FIH hydroxylation, answering what biochemical machine ASB4 belongs to.

   Evidence SOCS box complex biochemistry, Co-IP and hydroxylation assay with FIH, ES cell overexpression with oxygen-dependent vascular differentiation readout

   PMID:11111040 PMID:17636018

   Open questions at the time

   • Endogenous substrate(s) in ES/vascular context not identified
   • Functional consequence of hydroxylation on substrate degradation not directly demonstrated
3. 2007 Medium

   Revealed a SOCS-box-independent activity: ASB4 binds GPS1/CSN1 through its ankyrin repeats to suppress JNK and IRS-1 serine phosphorylation, expanding its role beyond canonical ligase function.

   Evidence Yeast two-hybrid, reciprocal Co-IP, SOCS box deletion mutant, JNK and IRS-1 phosphorylation assays in HEK293 cells

   PMID:17276034

   Open questions at the time

   • Whether GPS1 reduction is ubiquitin-dependent not resolved
   • In vivo relevance of the ASB4-GPS1-JNK axis untested
4. 2009 Medium

   Connected ASB4 to whole-animal energy balance by showing POMC-neuron overexpression alters food intake, body composition and metabolic rate, and that its hypothalamic expression responds to insulin and leptin.

   Evidence POMC-Asb4 transgenic mice, metabolic cage analysis, ICV insulin and IP leptin challenge, gene expression

   PMID:19934378

   Open questions at the time

   • Molecular substrate mediating the metabolic phenotype not identified in this study
   • Gain-of-function only; loss-of-function not yet tested
5. 2011 High

   Identified IRS4 as a neuronal substrate, providing a molecular substrate that links ASB4 ligase activity to attenuated insulin/AKT signaling in hypothalamic neurons.

   Evidence In situ co-localization, Co-IP in cells and endogenous hypothalamic extracts, SOCS box deletion mutant, ubiquitination and AKT phosphorylation assays

   PMID:21955513

   Open questions at the time

   • In vivo requirement of IRS4 degradation for the metabolic phenotype not established
   • Relationship between IRS4 and downstream feeding circuits unresolved
6. 2014 High

   Established ID2 as a physiological substrate in trophoblasts and connected ASB4-mediated ID2 degradation to placental differentiation and vascular patterning, with in vivo KO validation.

   Evidence Co-IP, ubiquitination assay, proteasome inhibition, degradation-resistant ID2 mutant rescue, endothelial co-culture, Asb4 knockout placental phenotyping

   PMID:24586788

   Open questions at the time

   • Whether FIH hydroxylation gates ID2 degradation not tested here
   • Upstream signals controlling ASB4 in trophoblasts not defined
7. 2014 Medium

   Implicated ASB4 in hepatocellular carcinoma cell motility and showed its mRNA is repressed by miR-200a, indicating a regulatory layer controlling ASB4 abundance.

   Evidence siRNA knockdown and overexpression in HCC cell lines, migration/invasion assays, dual luciferase reporter for miR-200a 3'UTR binding

   PMID:24815387

   Open questions at the time

   • Ligase substrate driving migration not identified
   • No in vivo tumor model
8. 2022 High

   Placed ASB4 in a defined feeding circuit: it acts downstream of AgRP, is fasting-suppressed, mediates calcitonin-induced satiety via Calcr, and controls glucose homeostasis specifically in POMC neurons.

   Evidence AgRP-KO epistasis, acute siRNA knockdown, global and POMC-specific Asb4 KO, calcitonin challenge, qPCR for Calcr, glucose tolerance testing

   PMID:35536884

   Open questions at the time

   • Direct ligase substrate controlling Calcr expression not identified
   • Mechanism coupling ASB4 loss to glucose intolerance unresolved
9. 2023 Medium

   Linked hyperinsulinemia to disease by showing that in ASB4 absence insulin elevates ID2 post-transcriptionally in trophoblasts, connecting failed ID2 degradation to preeclampsia pathology.

   Evidence Asb4-null mice on high-fat diet, placental ID2 protein vs mRNA, insulin/leptin treatment of HTR8/SVneo trophoblasts

   PMID:36768469

   Open questions at the time

   • Causal chain from insulin to ASB4 activity not mechanistically dissected
   • Direct demonstration that ID2 stabilization drives the phenotype absent

• How oxygen-dependent FIH hydroxylation, substrate selection (ID2, IRS4, GPS1), and tissue context are integrated to direct ASB4 between vascular/placental differentiation and hypothalamic energy homeostasis remains unresolved.
• No structural model of substrate recognition
• Hydroxylation-substrate degradation coupling not directly demonstrated for any substrate
• No unified in vivo test linking ligase activity to each phenotype